Product Code: ETC067004 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Thailand non-oncology precision medicine market is expected to witness significant growth in the coming years. Precision medicine refers to personalized healthcare that tailors medical treatment and interventions based on an individual`s genetic, environmental, and lifestyle factors. While precision medicine is commonly associated with oncology, its application is expanding to various non-oncology medical fields, including cardiology, neurology, and infectious diseases. The market`s expansion is driven by the increasing focus on personalized and targeted therapies to improve patient outcomes and treatment efficacy.
One of the key drivers of the Thailand non-oncology precision medicine market is the growing understanding of the role of genetics and molecular factors in disease development and progression. Advances in genomic sequencing and biomarker identification enable healthcare providers to make more informed treatment decisions. Moreover, the rising prevalence of chronic diseases, such as cardiovascular diseases and neurological disorders, supports the demand for precision medicine solutions to address the specific needs of patients. Additionally, the adoption of digital health technologies and data analytics enhances the integration of precision medicine into clinical practice, enabling more accurate diagnosis and treatment planning.
The Thailand non-oncology precision medicine market faces challenges related to data privacy and regulatory considerations. Safeguarding patient data and ensuring compliance with privacy regulations is crucial in precision medicine initiatives. Another challenge is the cost and accessibility of precision medicine technologies and therapies, which may limit their widespread adoption.
The Covid-19 pandemic had an impact on the Thailand non-oncology precision medicine market. During the pandemic, healthcare resources may have been diverted to manage Covid-19 cases, potentially affecting the adoption of precision medicine solutions for non-oncology conditions. However, as healthcare systems recover and focus on patient-centric approaches, the demand for personalized and targeted therapies is expected to drive the growth of the non-oncology precision medicine market. The importance of tailoring medical interventions to individual patients remains relevant in the post-pandemic period.
Key players in the Thailand non-oncology precision medicine market play a critical role in providing innovative technologies and treatment options. Some key players in the market include Thermo Fisher Scientific Inc., Illumina, Inc., and Novartis AG. These companies offer a range of precision medicine solutions, including genetic testing services, molecular diagnostics, and targeted therapies for various non-oncology conditions. As the demand for personalized healthcare continues to grow, these key players are expected to remain influential in shaping the non-oncology precision medicine market in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Non-Oncology Precision Medicine Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Thailand Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Thailand Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Thailand Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Thailand Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Non-Oncology Precision Medicine Market Trends |
6 Thailand Non-Oncology Precision Medicine Market, By Types |
6.1 Thailand Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2021-2031F |
6.1.4 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.5 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2021-2031F |
6.1.6 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2021-2031F |
6.1.7 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2021-2031F |
6.2 Thailand Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2021-2031F |
6.2.3 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2021-2031F |
6.2.4 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2021-2031F |
7 Thailand Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Thailand Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Thailand Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Thailand Non-Oncology Precision Medicine Market Key Performance Indicators |
9 Thailand Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Thailand Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Thailand Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Thailand Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Thailand Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 Thailand Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |